Candriam S.C.A. Boston Scientific Corp Transaction History

Candriam S.C.A.

$16.8 Billion
Q2 2025

A detailed history of Candriam S.C.A. transactions in Boston Scientific Corp stock. As of the latest transaction made, Candriam S.C.A. holds 836,025 shares of BSX stock, worth $85.6 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

836,025

Previous 415,162 101.37%

Holding current value

$85.6 Million

Previous $41.9 Million 114.41%

% of portfolio

0.54%

Previous 0.27%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$89.7 - $107.41 $37.8 Million - $45.2 Million	420,863 Added 101.37%	836,025 $89.8 Million
Q1 2025 May 14, 2025	BUY	$89.38 - $106.18 $2.09 Million - $2.49 Million	23,404 Added 5.97%	415,162 $41.9 Million
Q4 2024 Feb 06, 2025	SELL	$83.62 - $91.5 $6.95 Million - $7.61 Million	-83,157 Reduced 17.51%	391,758 $35 Million
Q3 2024 Nov 13, 2024	BUY	$72.96 - $84.0 $2.79 Million - $3.21 Million	38,174 Added 8.74%	474,915 $39.8 Million
Q2 2024 Aug 05, 2024	BUY	$67.33 - $77.71 $924,440 - $1.07 Million	13,730 Added 3.25%	436,741 $33.6 Million
Q1 2024 May 03, 2024	SELL	$57.6 - $68.62 $3.71 Million - $4.43 Million	-64,488 Reduced 13.23%	423,011 $29 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $2.1 Million - $2.5 Million	43,268 Added 9.74%	487,499 $28.2 Million
Q3 2023 Nov 13, 2023	BUY	$50.19 - $54.68 $5.28 Million - $5.75 Million	105,227 Added 31.04%	444,231 $23.5 Million
Q2 2023 Aug 08, 2023	SELL	$49.72 - $54.64 $3.67 Million - $4.03 Million	-73,721 Reduced 17.86%	339,004 $18.3 Million
Q1 2023 May 12, 2023	BUY	$45.09 - $50.03 $759,631 - $842,855	16,847 Added 4.26%	412,725 $20.6 Million
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $1.72 Million - $2.05 Million	-43,458 Reduced 9.89%	395,878 $18.3 Million
Q3 2022 Nov 10, 2022	BUY	$36.71 - $109.66 $7.97 Million - $23.8 Million	217,121 Added 97.71%	439,336 $17 Million
Q2 2022 Aug 03, 2022	BUY	$35.24 - $47.1 $5.16 Million - $6.89 Million	146,361 Added 192.95%	222,215 $8.28 Million
Q1 2022 May 13, 2022	BUY	$40.9 - $45.1 $60,654 - $66,883	1,483 Added 1.99%	75,854 $3.36 Million
Q4 2021 Feb 10, 2022	SELL	$38.07 - $44.87 $335,815 - $395,798	-8,821 Reduced 10.6%	74,371 $3.16 Million
Q3 2021 Nov 09, 2021	BUY	$41.23 - $45.88 $3,092 - $3,441	75 Added 0.09%	83,192 $3.61 Million
Q2 2021 Jul 20, 2021	SELL	$38.58 - $44.24 $124,073 - $142,275	-3,216 Reduced 3.73%	83,117 $3.55 Million
Q4 2020 Jan 22, 2021	BUY	$33.15 - $41.97 $369,058 - $467,252	11,133 Added 14.8%	86,333 $3.1 Million
Q3 2020 Oct 19, 2020	SELL	$34.44 - $42.23 $208,947 - $256,209	-6,067 Reduced 7.47%	75,200 $2.87 Million
Q2 2020 Jul 23, 2020	SELL	$30.19 - $39.11 $612,434 - $793,385	-20,286 Reduced 19.98%	81,267 $2.85 Million
Q4 2019 Jan 21, 2020	SELL	$37.87 - $45.37 $206,921 - $247,901	-5,464 Reduced 5.11%	101,553 $5,000
Q3 2019 Oct 21, 2019	BUY	$40.31 - $43.45 $111,860 - $120,573	2,775 Added 2.66%	107,017 $4,000
Q2 2019 Aug 01, 2019	SELL	$34.91 - $42.98 $204,258 - $251,475	-5,851 Reduced 5.31%	104,242 $4.46 Million
Q1 2019 May 02, 2019	BUY	$32.91 - $40.75 $128,316 - $158,884	3,899 Added 3.67%	110,093 $4.23 Million
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $88,558 - $108,960	-2,791 Reduced 2.56%	106,194 $3.75 Million
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $137,742 - $176,130	5,132 Added 4.94%	108,985 $3.56 Million
Q4 2017 Feb 07, 2018	SELL	$24.79 - $29.8 $89,566 - $107,667	-3,613 Reduced 3.36%	103,853 $2.58 Million
Q3 2017 Nov 03, 2017	BUY	$26.26 - $29.17 $2.82 Million - $3.13 Million	107,466	107,466 $3.14 Million

Others Institutions Holding BSX

# of Institutions

1,929

Shares Held

1.27B

Call Options Held

9.59M

Put Options Held

7.17M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $147B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account